(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 148.37%21.14M | -81.99%-9.01M | -16.22%-43.7M | 7.96%-110.04M | 22.27%-23.79M | -19.99%-43.7M | 72.59%-4.95M | -9.07%-37.6M | 8.72%-119.55M | 38.18%-30.61M |
Net income from continuing operations | -70.99%-33.95M | -63.44%-19.27M | -39.23%-21.7M | -683.75%-103.77M | -1,119.16%-56.54M | -15.42%-19.85M | -131.42%-11.79M | -841.21%-15.58M | 141.03%17.78M | -116.41%-4.64M |
Operating gains losses | -188.16%-10.45M | -213.14%-24.53M | -189.73%-14.86M | 70.14%-30.05M | 12.84%-13.46M | 44.55%-3.63M | 86.25%-7.83M | 76.33%-5.13M | -17.33%-100.65M | 66.67%-15.45M |
Depreciation and amortization | 24.92%9.04M | 63.78%9.11M | 64.59%8.09M | 126.88%26.07M | 124.50%8.36M | 137.65%7.24M | 103.03%5.56M | 147.76%4.91M | 118.51%11.49M | 126.63%3.72M |
Asset impairment expenditure | ---- | ---- | ---- | 9,927.61%48.02M | ---- | ---- | ---- | ---- | --478.89K | ---- |
Remuneration paid in stock | -66.91%438.19K | -77.32%466.45K | -71.66%400.64K | -57.91%5.2M | -83.80%408.64K | -50.63%1.32M | -38.84%2.06M | -62.74%1.41M | -82.61%12.36M | -50.36%2.52M |
Other non cashItems | 111.43%6.13M | --5.53M | --5.5M | 219.98%2.46M | ---441.56K | --2.9M | ---- | ---- | -141.41%-2.05M | --0 |
Change In working capital | 257.60%49.93M | 179.13%19.69M | 8.98%-21.13M | 1.68%-57.97M | 41.25%-10.13M | -72.12%-31.68M | 374.61%7.05M | -11.91%-23.22M | 29.08%-58.97M | 54.68%-17.25M |
-Change in receivables | 148.12%9.4M | 208.36%22.95M | 62.80%-9.45M | 45.21%-13.35M | --24.13M | ---19.53M | 37.95%7.44M | -7,942.13%-25.4M | -40.38%-24.37M | ---- |
-Change in inventory | 158.40%17.22M | 115.49%4.74M | 199.06%7.52M | -45.88%-90.06M | ---22.37M | ---29.48M | -172.76%-30.62M | 71.64%-7.59M | 21.48%-61.74M | ---- |
-Change in prepaid assets | -111.57%-383.74K | 207.90%1.66M | -219.00%-2.25M | 505.87%3.82M | --670.63K | --3.32M | 138.11%537.93K | -423.58%-706.03K | 78.65%-940.82K | ---- |
-Change in payables and accrued expense | 297.21%31.76M | -127.63%-8.18M | -203.37%-10.74M | -13.86%24.06M | ---8.7M | --7.99M | 533.63%29.62M | 90.06%10.39M | 61.94%27.93M | ---- |
-Change in other working capital | -233.80%-8.06M | -1,929.84%-1.48M | -7,785.35%-6.21M | 11,213.79%17.56M | ---3.87M | --6.03M | --80.75K | --80.75K | --155.25K | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 148.37%21.14M | -81.99%-9.01M | -16.22%-43.7M | 7.96%-110.04M | 22.27%-23.79M | -19.99%-43.7M | 72.59%-4.95M | -9.07%-37.6M | 8.72%-119.55M | 38.18%-30.61M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 91.09%-3.28M | 62.30%-11.62M | 58.98%-11.81M | 39.64%-123.51M | 52.55%-27.15M | 9.59%-36.76M | 45.13%-30.81M | 43.08%-28.79M | -226.86%-204.61M | -100.71%-57.22M |
Net PPE purchase and sale | 93.59%-1.44M | 91.22%-1.56M | 45.97%-3.82M | 55.40%-57.79M | 73.51%-10.5M | -2.38%-22.39M | 44.75%-17.81M | 80.23%-7.08M | -553.46%-129.55M | -279.83%-39.64M |
Net intangibles purchas and sale | 71.32%-4.6M | 39.61%-11.32M | 48.80%-11.11M | 3.97%-75.17M | 10.31%-18.66M | 14.54%-16.06M | 21.58%-18.75M | -46.86%-21.71M | -74.13%-78.28M | -13.64%-20.81M |
Net other investing changes | 63.61%2.77M | -77.91%1.27M | --3.13M | 192.96%9.45M | --2.01M | --1.69M | --5.75M | ---- | 47.82%3.23M | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 91.09%-3.28M | 62.30%-11.62M | 58.98%-11.81M | 39.64%-123.51M | 52.55%-27.15M | 9.59%-36.76M | 45.13%-30.81M | 43.08%-28.79M | -226.86%-204.61M | -100.71%-57.22M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -92.27%5.61M | -58.94%17.78M | 117.02%30.43M | 1.53%175.45M | -58.19%45.51M | 15.34%72.61M | 1,620.39%43.31M | 1,022.25%14.02M | -60.25%172.8M | 45,546.82%108.85M |
Net issuance payments of debt | -92.01%5.61M | -57.35%17.78M | 1,214.48%30.43M | 66.02%159.79M | -11.62%45.51M | 60.55%70.27M | 1,558.79%41.7M | 252.27%2.32M | 235.72%96.25M | 8,147.19%51.49M |
Net common stock issuance | --0 | --0 | --0 | -77.47%12.76M | --0 | -87.80%2.34M | --1.61M | --8.8M | -88.78%56.62M | --37.43M |
Proceeds from stock option exercised by employees | --0 | --0 | --0 | -85.42%2.91M | --0 | --0 | --0 | --2.91M | 1,672.22%19.94M | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -92.27%5.61M | -58.94%17.78M | 117.02%30.43M | 1.53%175.45M | -58.19%45.51M | 15.34%72.61M | 1,620.39%43.31M | 1,022.25%14.02M | -60.25%172.8M | 45,546.82%108.85M |
Net cash flow | ||||||||||
Beginning cash position | -95.46%2M | -86.66%4.8M | -66.13%29.89M | -63.48%88.27M | -46.45%35.67M | -46.81%44.15M | -76.86%35.97M | -63.48%88.27M | 265,484.99%241.7M | -79.04%66.61M |
Current changes in cash | 399.12%23.47M | -137.58%-2.84M | 52.11%-25.07M | 61.62%-58.09M | -125.84%-5.43M | 44.45%-7.85M | 110.54%7.55M | 39.51%-52.36M | -162.77%-151.36M | 126.87%21.02M |
Effect of exchange rate changes | 227.54%811.89K | -93.32%41.83K | -125.89%-18K | 86.26%-285.55K | -154.74%-344.32K | 71.89%-636.56K | 181.22%625.79K | -78.80%69.54K | -413.20%-2.08M | -70.19%628.96K |
End cash Position | -26.30%26.29M | -95.46%2M | -86.66%4.8M | -66.13%29.89M | -66.13%29.89M | -46.45%35.67M | -46.81%44.15M | -76.86%35.97M | -63.48%88.27M | -63.48%88.27M |
Free cash from | 118.38%15.1M | 47.26%-21.89M | 32.52%-58.64M | 19.52%-263.5M | 41.85%-52.95M | -6.54%-82.15M | 44.06%-41.51M | -2.17%-86.89M | -67.26%-327.41M | -16.36%-91.05M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data